Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence

Katherine Krauskopf*, Alex D. Federman, Minal S. Kale, Keith M. Sigel, Melissa Martynenko, Rachel O'Conor, Michael S. Wolf, Howard Leventhal, Juan P. Wisnivesky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

Almost half of patients with COPD do not adhere to their medications. Illness and medication beliefs are important determinants of adherence in other chronic diseases. Using the framework of the Common Sense Model of Self-Regulation (CSM), we determined associations between potentially modifiable beliefs and adherence to COPD medications in a cohort of English- and Spanish-speaking adults with COPD from New York and Chicago. Medication adherence was assessed using the Medication Adherence Report Scale. Illness and medication beliefs along CSM domains were evaluated using the Brief Illness Perception Questionnaire (B-IPQ) and the Beliefs about Medications Questionnaire (BMQ). Unadjusted analysis (with Cohen's d effect sizes) and multiple logistic regression were used to assess the relationship between illness and medication beliefs with adherence. The study included 188 participants (47% Black, 13% Hispanics); 109 (58%) were non-adherent. Non-adherent participants were younger (p < 0.001), more likely to be Black or Hispanic (p = 0.001), to have reported low income (p = 0.02), and had fewer years of formal education (p = 0.002). In unadjusted comparisons, non-adherent participants reported being more concerned about their COPD (p = 0.011; Cohen's d = 0.43), more emotionally affected by the disease (p = 0.001; Cohen's d = 0.54), and had greater concerns about COPD medications (p < 0.001, Cohen's d = 0.81). In adjusted analyses, concerns about COPD medications independently predicted non-adherence (odds ratio: 0.52, 95% confidence interval: 0.36-0.75). In this cohort of urban minority adults, concerns about medications were associated with non-adherence. Future work should explore interventions to influence patient adherence by addressing concerns about the safety profile and long-term effects of COPD medications.

Original languageEnglish (US)
Pages (from-to)151-164
Number of pages14
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume12
Issue number2
DOIs
StatePublished - Apr 14 2015

Funding

Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R01HL105385. No conflicts of interest exist for the following authors: Katherine Krauskopf, Minal S. Kale, Keith Sigel, Melissa Martynenko, Rachel O’Conor, Alex D. Federman, or Howard Leventhal. Michael S. Wolf has research grant support from Merck Sharp & Dohme, McNeil Consumer Health, Abbvie, Land of Lincoln Health, and United Healthcare. Additionally, Dr. Wolf, serves as a consultant for Merck, McNeil Consumer health, Abbot Laboratory, and Luto Ltd. Lastly, he received Honoraria from Eli Lilly and CoMed. Juan P. Wisnivesky is a member of the research board of EHE International, has received consulting fees from Merck, UBS and IMS Health, and was awarded a research grant from GlaxoSmithKline to conduct a COPD study.

Keywords

  • Health beliefs
  • Outcomes
  • Self-management
  • Vulnerable population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence'. Together they form a unique fingerprint.

Cite this